GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MediPharm Labs Corp (TSX:LABS) » Definitions » GF Value

MediPharm Labs (TSX:LABS) GF Value : C$0.09 (As of Mar. 23, 2025)


View and export this data going back to 2018. Start your Free Trial

What is MediPharm Labs GF Value?

As of today (2025-03-23), MediPharm Labs's share price is C$0.11. MediPharm Labs's GF Value is C$0.09. Therefore, MediPharm Labs's Price-to-GF-Value for today is 1.22. Based on the relationship between the current stock price and the GF Value, GuruFocus believes MediPharm Labs is Modestly Overvalued.

The GF Value represents the intrinsic value of a stock, determined using GuruFocus' proprietary methodology. The GF Value Line on our stock Summary page provides an estimate of the stock’s fair-trading value.

To calculate this value, GuruFocus follows these steps:

  1. We analyze historical correlations between the stock price and key business performance metrics, such as revenue, earnings, cash flow, and book value.
  2. We identify the metrics that have the strongest historical correlation with the stock price and determine the historical multiples at which the stock has traded relative to these metrics.
  3. Using these historical multiples as a reference, we estimate the stock's fair value while accounting for future business growth. Adjustments may be made based on the company’s past returns and growth trends.

GuruFocus believes that the GF Value Line represents the fair value at which a stock should trade. Stock prices typically fluctuate around this line. If a stock’s price is significantly above the GF Value Line, it is considered overvalued, and its future returns are likely to be lower. Conversely, if the stock price is significantly below the GF Value Line, its future returns are likely to be higher.

Please note that "Possible Value Trap, Think Twice" applies to companies that appear significantly undervalued but are either experiencing a long-term business decline or facing financial distress.

MediPharm Labs  (TSX:LABS) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 ratings:

Posssible Evaluations All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)Predictable Companies that possibly be Value Traps
Significantly OvervaluedPredictable Companies which are Significantly Overvalued
Modestly OvervaluedPredictable Companies which are Modestly Overvalued
Fairly ValuedPredictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" applies to companies that appear significantly undervalued but are either experiencing a long-term business decline or facing financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) A sufficient margin of safety exists only when the stock is undervalued.

MediPharm Labs's Price-to-GF-Value for today is calculated as

Price-to-GF-Value=Share Price/GF Value
=0.11/0.09
=1.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MediPharm Labs GF Value Related Terms

Thank you for viewing the detailed overview of MediPharm Labs's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

MediPharm Labs Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MediPharm Labs Corp (TSX:LABS) » Definitions » GF Value
Comparable Companies
XCNQ:RWB TSXV:VM XCNQ:CXXI TSX:AVCN XCNQ:EPIC TSX:CWEB TSXV:ROMJ XCNQ:OPTI XCNQ:FFNT XCNQ:QNTM ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB HKSE:03692
Traded in Other Exchanges
MEDIF:USA MLZ:Germany
Address
151 John Street, Barrie, ON, CAN, L4N 2L1
Website
https://www.medipharmlabs.com
MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis flower, extracts, and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets. Geographically the company has a presence in Canada, Australia, Germany, and other countries and the majority of revenue derives from Canada.
Executives
Keith Strachan Director
Gregory Edison Hunter Senior Officer
David Pidduck Director, Senior Officer
Bryan Howcroft Director, Senior Officer
Patrick Mccutcheon Director
Warren Everitt Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Etf Managers Trust 10% Security Holder
Christopher David Taves Director
Sybil Taylor Senior Officer
Braden Fenske Senior Officer
David John Mayers Senior Officer

MediPharm Labs Headlines